GlassScriptPhysician profile
Aisha S Chaudhry
NPI 1326294471
$1,447.56
in general payments reported to CMS, 2019-2025
24 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $29.16 · 2021: $173 · 2022: $581 · 2023: $233 · 2024: $108 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $214.58 | 2021-2022 | |
| Abbott Laboratories | $163.98 | 2019-2025 | Proclaim |
| Vaporox, INC. | $150.21 | 2023 | Vht-200 Wound Treatment System |
| Resmed Corp | $97.64 | 2022 | |
| Paragon 28, INC. | $89.44 | 2019 | |
| Nevro Corp. | $88.46 | 2022 | |
| Cashflow Solutions, LLC | $84.44 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Kci USA, INC. | $70.19 | 2020-2023 | Activ.A.C., Promogran Prisma |
| Zimmer Biomet Holdings, INC. | $66.43 | 2021 | |
| Treace Medical Concepts, INC. | $51.74 | 2022-2023 | |
| Horizon Therapeutics Plc | $44.63 | 2019-2021 | |
| Orthofix Medical, INC. | $42.67 | 2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $39.53 | 2022 | |
| Abbvie INC. | $35.46 | 2022 | |
| Nabriva Therapeutics, Plc | $23.77 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $23.59 | 2021 | |
| Acera Surgical, INC. | $23.44 | 2022 | |
| Boston Scientific Corporation | $22.68 | 2019 | |
| Solventum Corporation | $22.13 | 2025 | Activ.A.C. |
| Biotissue Holdings INC. | $21.67 | 2022 | |
| Medtronic, INC. | $18.89 | 2024 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $18.56 | 2022 | |
| Grt US Holding, INC. | $16.91 | 2022 | |
| Kerecis Limited | $16.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aisha Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.